Abstract
The skin, being in direct contact with several environmental factors (e.g. UV irradiation), does not only undergo endogenous aging, which has to do with the ‘biological clock’ of the skin cells per se, but also exogenous aging. While exogenous skin aging has been extensively studied, the pathomechanisms of endogenous skin aging remain far less clear. Endogenous skin aging reflects reduction processes, which are common in internal organs. These processes include cellular senescence and decreased proliferative capacity, decrease in cellular DNA repair capacity and chromosomal abnormalities, loss of telomeres, point mutations of extranuclear mtDNA, oxidative stress and gene mutations. As a consequence, aged skin in nonexposed areas shows typical characteristics including fine wrinkles, dryness, sallowness and loss of elasticity. Recent data have illustrated that lack of hormones occurring with age may also contribute to the aging phenotype. Improvement of epidermal skin moisture, elasticity and skin thickness, enhanced production of surface lipids, reduction of wrinkle depth, restoration of collagen fibers and increase of the collagen III/I ratio have been reported after hormone replacement therapy or local estrogen treatment in postmenopausal women. Furthermore, an in vitro model of endogenous skin aging consisting of human SZ95 sebocytes which were incubated under a hormone-substituted environment illustrated that hormones at age- and sex-specific levels were able to alter the development of cells by regulating their transcriptome. In conclusion, among other factors the hormone environment plays a distinct role in the generation of aged skin.
References
1.
Osiewacz HD: Genetic regulation of aging. J Mol Med 1997;75:715–727.
2.
Jazwinski SM: The RAS genes: a homeostatic device in Saccharomyces cerevisiae longevity. Neurobiol Aging 1999;20:471–478.
3.
Oeppen J, Vaupel JW: Demography: broken limits to life expectancy. Science 2002;296:1029–1031.
4.
Rittie L, Fisher GJ: UV-light-induced signal cascades and skin aging. Ageing Res Rev 2002;1:705–720.
5.
Uitto J: Connective tissue biochemistry of the aging dermis: age-related alterations in collagen and elastin. Dermatol Clin 1986;4:433–446.
6.
Fisher GJ, Kang S, Varani J, Bata-Csorgo Z, Wan Y, Datta S, Voorhees JJ: Mechanisms of photoaging and chronological skin aging. Arch Dermatol 2002;138:1462–1470.
7.
Podda M, Traber MG, Weber C, Yan LJ, Packer L: UV-irradiation depletes antioxidants and causes oxidative damage in a model of human skin. Free Radic Biol Med 1998;24:55–65.
8.
Evelson P, Ordonez CP, Llesuy S, Boveris A: Oxidative stress and in vivo chemiluminescence in mouse skin exposed to UVA radiation. J Photochem Photobiol B 1997;38:215–219.
9.
Kohen R: Skin antioxidants: their role in aging and in oxidative stress – new approaches for their evaluation. Biomed Pharmacother 1999;53:181–192.
10.
Moragas A, Castells C, Sans M: Mathematical morphologic analysis of aging-related epidermal changes. Anal Quant Cytol Histol 1993;15:75–82.
11.
Lock-Andersen J, Therkildsen P, de Fine Olivarius F, Gniadecka M, Dahlstrom K, Poulsen T, Wulf HC: Epidermal thickness, skin pigmentation and constitutive photosensitivity. Photodermatol Photoimmunol Photomed 1997;13:153–158.
12.
Lavker RM: Structural alterations in exposed and unexposed aged skin. J Invest Dermatol 1979;73:59–66.
13.
Bregegere F, Soroka Y, Bismuth J, Friguet B, Milner Y: Cellular senescence in human keratinocytes: unchanged proteolytic capacity and increased protein load. Exp Gerontol 2003;38:619–629.
14.
West MD: The cellular and molecular biology of skin aging. Arch Dermatol 1994;130:87–95.
15.
Engelke M, Jensen JM, Ekanayake-Mudiyanselage S, Proksch E: Effects of xerosis and ageing on epidermal proliferation and differentiation. Br J Dermatol 1997;137:219–225.
16.
Bauer FW, Crombag NH, de Grood RM, de Jongh GJ: Flow cytometry as a tool for the study of cell kinetics in epidermis. Br J Dermatol 1980;102:629–639.
17.
Grove GL, Kligman AM: Age-associated changes in human epidermal cell renewal. J Gerontol 1983;38:137–142.
18.
Lavker RM, Zheng PS, Dong G: Aged skin: a study by light, transmission electron, and scanning electron microscopy. J Invest Dermatol 1987;88:44s–51s.
19.
Yaar M, Gilchrest BA: Skin aging: postulated mechanisms and consequent changes in structure and function. Clin Geriatr Med 2001;17:617–630, v.
20.
Gilchrest BA, Blog FB, Szabo G: Effects of aging and chronic sun exposure on melanocytes in human skin. J Invest Dermatol 1979;73:141–143.
21.
Breathnach AS, Nazzaro-Porro M, Passi S, Picardo M: Ultrastructure of melanocytes in chronically sun-exposed skin of elderly subjects. Pigment Cell Res 1991;4:71–79.
22.
Ortonne JP: Pigmentary changes of the ageing skin. Br J Dermatol 1990;122(suppl 35):21–28.
23.
Na R, Stender IM, Henriksen M, Wulf HC: Autofluorescence of human skin is age-related after correction for skin pigmentation and redness. J Invest Dermatol 2001;116:536–540.
24.
Bhushan M, Cumberbatch M, Dearman RJ, Andrew SM, Kimber I, Griffiths CE: Tumour necrosis factor-alpha-induced migration of human Langerhans cells: the influence of ageing. Br J Dermatol 2002;146:32–40.
25.
Grewe M: Chronological ageing and photoageing of dendritic cells. Clin Exp Dermatol 2001;26:608–612.
26.
Varani J, Spearman D, Perone P, Fligiel SE, Datta SC, Wang ZQ, Shao Y, Kang S, Fisher GJ, Voorhees JJ: Inhibition of type I procollagen synthesis by damaged collagen in photoaged skin and by collagenase-degraded collagen in vitro. Am J Pathol 2001;158:931–942.
27.
Braverman IM, Fonferko E: Studies in cutaneous aging. I. The elastic fiber network. J Invest Dermatol 1982;78:434–443.
28.
Suwabe H, Serizawa A, Kajiwara H, Ohkido M, Tsutsumi Y: Degenerative processes of elastic fibers in sun-protected and sun-exposed skin: immunoelectron microscopic observation of elastin, fibrillin-1, amyloid P component, lysozyme and alpha1-antitrypsin. Pathol Int 1999;49:391–402.
29.
Braverman IM, Fonferko E: Studies in cutaneous aging. II. The microvasculature. J Invest Dermatol 1982;78:444–448.
30.
Ashcroft GS, Herrick SE, Tarnuzzer RW, Horan MA, Schultz GS, Ferguson MW: Human ageing impairs injury-induced in vivo expression of tissue inhibitor of matrix metalloproteinases (TIMP)-1 and -2 proteins and mRNA. J Pathol 1997;183:169–176.
31.
Eaglstein WH: Wound healing and aging. Clin Geriatr Med 1989;5:183–188.
32.
Hayflick L: The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965;37:614–636.
33.
Gilchrest BA: In vitro assessment of keratinocyte aging. J Invest Dermatol 1983;81:184s–189s.
34.
Schneider EL, Mitsui Y: The relationship between in vitro cellular aging and in vivo human age. Proc Natl Acad Sci USA 1976;73:3584–3588.
35.
Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, et al: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995;92:9363–9367.
36.
Kosmadaki MG, Gilchrest BA: The role of telomeres in skin aging/photoaging. Micron 2004;35:155–159.
37.
Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE: Extension of life-span by introduction of telomerase into normal human cells. Science 1998;279:349– 352.
38.
Smith JR, Pereira-Smith OM: Replicative senescence: implications for in vivo aging and tumor suppression. Science 1996;273:63–67.
39.
Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992;89:10114–10118.
40.
Michikawa Y, Mazzucchelli F, Bresolin N, Scarlato G, Attardi G: Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science 1999;286:774–779.
41.
Miquel J: An update on the oxygen stress-mitochondrial mutation theory of aging: genetic and evolutionary implications. Exp Gerontol 1998;33:113–126.
42.
Benn PA: Specific chromosome aberrations in senescent fibroblast cell lines derived from human embryos. Am J Hum Genet 1976;28:465–473.
43.
Ly DH, Lockhart DJ, Lerner RA, Schultz PG: Mitotic misregulation and human aging. Science 2000;287:2486–2492.
44.
Mets T, Bekaert E, Verdonk G: Similarity between in vitro and in vivo cellular aging. Mech Ageing Dev 1983;22:71–78.
45.
Cristofalo VJ, Pignolo RJ: Replicative senescence of human fibroblast-like cells in culture. Physiol Rev 1993;73:617–638.
46.
Gilchrest BA, Vrabel MA, Flynn E, Szabo G: Selective cultivation of human melanocytes from newborn and adult epidermis. J Invest Dermatol 1984;83:370–376.
47.
Harley CB: Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991;256:271–282.
48.
Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J, Dalla-Favera R: Direct activation of TERT transcription by c-MYC. Nat Genet 1999;21:220–224.
49.
Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, et al: The RNA component of human telomerase. Science 1995;269:1236–1241.
50.
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011–2015.
51.
Harley CB, Futcher AB, Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 1990;345:458–460.
52.
Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC: Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990;346:866–868.
53.
Chang E, Harley CB: Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 1995;92:11190–11194.
54.
Weng NP, Granger L, Hodes RJ: Telomere lengthening and telomerase activation during human B cell differentiation. Proc Natl Acad Sci USA 1997;94:10827–10832.
55.
Wallace DC: Mitochondrial defects in neurodegenerative disease. Ment Retard Dev Disabil Res Rev 2001;7:158–166.
56.
Guarente L, Kenyon C: Genetic pathways that regulate ageing in model organisms. Nature 2000;408:255–262.
57.
Robert L, Robert AM: Aging, from basic research to pathological applications. Pathol Biol (Paris) 2003;51:543–549.
58.
Johnson TE, Henderson S, Murakami S, de Castro E, de Castro SH, Cypser J, Rikke B, Tedesco P, Link C: Longevity genes in the nematode Caenorhabditis elegans also mediate increased resistance to stress and prevent disease. J Inherit Metab Dis 2002;25:197–206.
59.
Rogina B, Reenan RA, Nilsen SP, Helfand SL: Extended life-span conferred by cotransporter gene mutations in Drosophila. Science 2000;290:2137–2140.
60.
Tatar M, Kopelman A, Epstein D, Tu MP, Yin CM, Garofalo RS: A mutant Drosophila insulin receptor homolog that extends life span and impairs neuroendocrine function. Science 2001;292:107–110.
61.
Arking R, Buck S, Hwangbo DS, Lane M: Metabolic alterations and shifts in energy allocations are corequisites for the expression of extended longevity genes in Drosophila. Ann NY Acad Sci 2002;959:251–262; discussion 463–465.
62.
Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI: Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997;390:45–51.
63.
Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, Matthews S, Nakura J, Miki T, Ouais S, Martin GM, Mulligan J, Schellenberg GD: Positional cloning of the Werner’s syndrome gene. Science 1996;272:258–262.
64.
Rattan SI: Aging, anti-aging, and hormesis. Mech Ageing Dev 2004;125:285–289.
65.
Partridge L, Gems D: A lethal side-effect. Nature 2002;418:921.
66.
Gilchrest BA, Garmyn M, Yaar M: Aging and photoaging affect gene expression in cultured human keratinocytes. Arch Dermatol 1994;130:82–86.
67.
Yaar M, Eller MS, Bhawan J, Harkness DD, DiBenedetto PJ, Gilchrest BA: In vivo and in vitro SPRR1 gene expression in normal and malignant keratinocytes. Exp Cell Res 1995;217:217–226.
68.
Seshadri T, Campisi J: Repression of c-fos transcription and an altered genetic program in senescent human fibroblasts. Science 1990;247:205–209.
69.
Hara E, Yamaguchi T, Nojima H, Ide T, Campisi J, Okayama H, Oda K: Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J Biol Chem 1994;269:2139–2145.
70.
Simard M, Manthos H, Giaid A, Lefebvre Y, Goodyer CG: Ontogeny of growth hormone receptors in human tissues: an immunohistochemical study. J Clin Endocrinol Metab 1996;81:3097–3102.
71.
Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994;211:90–98.
72.
Jenkins G: Molecular mechanisms of skin ageing. Mech Ageing Dev 2002;123:801–810.
73.
Uitto J: Biochemistry of the elastic fibers in normal connective tissues and its alterations in diseases. J Invest Dermatol 1979;72:1–10.
74.
Chung JH, Kang S, Varani J, Lin J, Fisher GJ, Voorhees JJ: Decreased extracellular-signal-regulated kinase and increased stress-activated MAP kinase activities in aged human skin in vivo. J Invest Dermatol 2000;115:177–182.
75.
Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995;270:1326–1331.
76.
Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, Kolesnick RN: Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996;380:75–79.
77.
Zeng G, McCue HM, Mastrangelo L, Millis AJ: Endogenous TGF-beta activity is modified during cellular aging: effects on metalloproteinase and TIMP-1 expression. Exp Cell Res 1996;228:271–276.
78.
Wick M, Burger C, Brusselbach S, Lucibello FC, Muller R: A novel member of human tissue inhibitor of metalloproteinases (TIMP) gene family is regulated during G1 progression, mitogenic stimulation, differentiation, and senescence. J Biol Chem 1994;269:18953–18960.
79.
Mori Y, Hatamochi A, Arakawa M, Ueki H: Reduced expression of mRNA for transforming growth factor beta (TGF beta) and TGF beta receptors I and II and decreased TGF beta binding to the receptors in in vitro-aged fibroblasts. Arch Dermatol Res 1998;290:158–162.
80.
Corpas E, Harman SM, Blackman MR: Human growth hormone and human aging. Endocr Rev 1993;14:20–39.
81.
Beckman KB, Ames BN: Oxidative decay of DNA. J Biol Chem 1997;272:19633–19636.
82.
Ames BN, Shigenaga MK, Hagen TM: Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993;90:7915–7922.
83.
Lopez-Torres M, Shindo Y, Packer L: Effect of age on antioxidants and molecular markers of oxidative damage in murine epidermis and dermis. J Invest Dermatol 1994;102:476–480.
84.
Shigenaga MK, Ames BN: Assays for 8-hydroxy-2´-deoxyguanosine: a biomarker of in vivo oxidative DNA damage. Free Radic Biol Med 1991;10:211–216.
85.
Hu HL, Forsey RJ, Blades TJ, Barratt ME, Parmar P, Powell JR: Antioxidants may contribute in the fight against ageing: an in vitro model. Mech Ageing Dev 2000;121:217–230.
86.
Sohal RS, Weindruch R: Oxidative stress, caloric restriction, and aging. Science 1996;273:59–63.
87.
Hensley K, Floyd RA: Reactive oxygen species and protein oxidation in aging: a look back, a look ahead. Arch Biochem Biophys 2002;397:377–383.
88.
Affinito P, Palomba S, Sorrentino C, Di Carlo C, Bifulco G, Arienzo MP, Nappi C: Effects of postmenopausal hypoestrogenism on skin collagen. Maturitas 1999;33:239–247.
89.
Snowdon DA: Early natural menopause and the duration of postmenopausal life: findings from a mathematical model of life expectancy. J Am Geriatr Soc 1990;38:402–408.
90.
Gems D, Partridge L: Insulin/IGF signalling and ageing: seeing the bigger picture. Curr Opin Genet Dev 2001;11:287–292.
91.
Bartke A, Coschigano K, Kopchick J, Chandrashekar V, Mattison J, Kinney B, Hauck S: Genes that prolong life: relationships of growth hormone and growth to aging and life span. J Gerontol A Biol Sci Med Sci 2001;56:B340–B349.
92.
Simon AF, Shih C, Mack A, Benzer S: Steroid control of longevity in Drosophila melanogaster. Science 2003;299:1407–1410.
93.
Tatar M, Bartke A, Antebi A: The endocrine regulation of aging by insulin-like signals. Science 2003;299:1346–1351.
94.
Miller KK: Androgen deficiency in women. J Clin Endocrinol Metab 2001;86:2395–2401.
95.
Roshan S, Nader S, Orlander P: Review: ageing and hormones. Eur J Clin Invest 1999;29:210–213.
96.
Yen SS, Laughlin GA: Aging and the adrenal cortex. Exp Gerontol 1998;33:897–910.
97.
Tenover JL: Testosterone and the aging male. J Androl 1997;18:103–106.
98.
Simon D, Preziosi P, Barrett-Connor E, Roger M, Saint-Paul M, Nahoul K, Papoz L: The influence of aging on plasma sex hormones in men: the Telecom Study. Am J Epidemiol 1992;135:783–791.
99.
Gray A, Feldman HA, McKinlay JB, Longcope C: Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991;73:1016–1025.
100.
Russell-Aulet M, Dimaraki EV, Jaffe CA, DeMott-Friberg R, Barkan AL: Aging-related growth hormone (GH) decrease is a selective hypothalamic GH-releasing hormone pulse amplitude mediated phenomenon. J Gerontol A Biol Sci Med Sci 2001;56:M124–M129.
101.
Zouboulis CC: Human skin: an independent peripheral endocrine organ. Horm Res 2000;54:230–242.
102.
Brincat MP: Hormone replacement therapy and the skin. Maturitas 2000;35:107–117.
103.
Fuchs KO, Solis O, Tapawan R, Paranjpe J: The effects of an estrogen and glycolic acid cream on the facial skin of postmenopausal women: a randomized histologic study. Cutis 2003;71:481–488.
104.
Sator PG, Schmidt JB, Sator MO, Huber JC, Honigsmann H: The influence of hormone replacement therapy on skin ageing: a pilot study. Maturitas 2001;39:43–55.
105.
Schmidt JB, Binder M, Demschik G, Bieglmayer C, Reiner A: Treatment of skin aging with topical estrogens. Int J Dermatol 1996;35:669–674.
106.
Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA: Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005;433:760–764.
107.
Makrantonaki E, Adjaye J, Herwig R, Brink TC, Groth D, Hultschig C, Lehrach H, Zouboulis CC: Age-specific hormonal decline is accompanied by transcriptional changes in human sebocytes in vitro. Aging Cell 2006;5:331–344.
108.
Adjaye J: Whole-genome approaches for large-scale gene identification and expression analysis in mammalian preimplantation embryos. Reprod Fertil Dev 2005;17:37–45.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
